Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man

Leticia Castillo, T. C. DeRojas, T. E. Chapman, J. Vogt, J. F. Burke, S. R. Tannenbaum, Vernon R. Young

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Urinary nitrate (NO3) is the stable end product of nitric oxide, which is formed, in turn, from a guanidino nitrogen of arginine. We have conducted two experiments, each in four healthy adult men receiving a low nitrate diet for 7-10 days, to investigate the in vivo conversion of arginine to nitrate. In the first study [guanidino-15N2, 5,5-2H2]arginine was given on day 7 via a primed continuous intravenous infusion for 8 h. In the second study, the labeled arginine was given for 8 h by the intragastric route on day 7 and by the intravenous route on day 10. Measurement of 15NO3 output in urine collected for 24 h beginning at the time of the arginine tracer infusion revealed a more extensive transfer of 15N when the arginine tracer was given intragastricly. From the comparative labeling of 15NO3 after administration of the tracer arginine via the intragastric and intravenous routes, we estimate that 16% ± 2% of the daily production of nitrate arises from the metabolism of dietary arginine that is taken up during its "first pass" in the splanchnic region. Hence, nitric oxide production occurs, to a measurable extent, in this area in healthy subjects, raising the question as to how various pathophysiological states might alter the relations between exogenous and endogenous sources of arginine as precursors of NO· and the relative contributions made by various organs to whole body (NO·) NO3 formation. These results also raise important questions about the use of nitric oxide synthase inhibitors in animal and human studies.

Original languageEnglish (US)
Pages (from-to)193-197
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume90
Issue number1
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Viscera
Arginine
Nitric Oxide
Nitrates
Intravenous Infusions
Nitric Oxide Synthase
Healthy Volunteers
Nitrogen
Urine
Diet

ASJC Scopus subject areas

  • General

Cite this

Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. / Castillo, Leticia; DeRojas, T. C.; Chapman, T. E.; Vogt, J.; Burke, J. F.; Tannenbaum, S. R.; Young, Vernon R.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 90, No. 1, 01.01.1993, p. 193-197.

Research output: Contribution to journalArticle

Castillo, Leticia ; DeRojas, T. C. ; Chapman, T. E. ; Vogt, J. ; Burke, J. F. ; Tannenbaum, S. R. ; Young, Vernon R. / Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. In: Proceedings of the National Academy of Sciences of the United States of America. 1993 ; Vol. 90, No. 1. pp. 193-197.
@article{71b6cbb4a11b484f8af6e5d8d3b674ba,
title = "Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man",
abstract = "Urinary nitrate (NO3) is the stable end product of nitric oxide, which is formed, in turn, from a guanidino nitrogen of arginine. We have conducted two experiments, each in four healthy adult men receiving a low nitrate diet for 7-10 days, to investigate the in vivo conversion of arginine to nitrate. In the first study [guanidino-15N2, 5,5-2H2]arginine was given on day 7 via a primed continuous intravenous infusion for 8 h. In the second study, the labeled arginine was given for 8 h by the intragastric route on day 7 and by the intravenous route on day 10. Measurement of 15NO3 output in urine collected for 24 h beginning at the time of the arginine tracer infusion revealed a more extensive transfer of 15N when the arginine tracer was given intragastricly. From the comparative labeling of 15NO3 after administration of the tracer arginine via the intragastric and intravenous routes, we estimate that 16{\%} ± 2{\%} of the daily production of nitrate arises from the metabolism of dietary arginine that is taken up during its {"}first pass{"} in the splanchnic region. Hence, nitric oxide production occurs, to a measurable extent, in this area in healthy subjects, raising the question as to how various pathophysiological states might alter the relations between exogenous and endogenous sources of arginine as precursors of NO· and the relative contributions made by various organs to whole body (NO·) NO3 formation. These results also raise important questions about the use of nitric oxide synthase inhibitors in animal and human studies.",
author = "Leticia Castillo and DeRojas, {T. C.} and Chapman, {T. E.} and J. Vogt and Burke, {J. F.} and Tannenbaum, {S. R.} and Young, {Vernon R.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1073/pnas.90.1.193",
language = "English (US)",
volume = "90",
pages = "193--197",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "1",

}

TY - JOUR

T1 - Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man

AU - Castillo, Leticia

AU - DeRojas, T. C.

AU - Chapman, T. E.

AU - Vogt, J.

AU - Burke, J. F.

AU - Tannenbaum, S. R.

AU - Young, Vernon R.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Urinary nitrate (NO3) is the stable end product of nitric oxide, which is formed, in turn, from a guanidino nitrogen of arginine. We have conducted two experiments, each in four healthy adult men receiving a low nitrate diet for 7-10 days, to investigate the in vivo conversion of arginine to nitrate. In the first study [guanidino-15N2, 5,5-2H2]arginine was given on day 7 via a primed continuous intravenous infusion for 8 h. In the second study, the labeled arginine was given for 8 h by the intragastric route on day 7 and by the intravenous route on day 10. Measurement of 15NO3 output in urine collected for 24 h beginning at the time of the arginine tracer infusion revealed a more extensive transfer of 15N when the arginine tracer was given intragastricly. From the comparative labeling of 15NO3 after administration of the tracer arginine via the intragastric and intravenous routes, we estimate that 16% ± 2% of the daily production of nitrate arises from the metabolism of dietary arginine that is taken up during its "first pass" in the splanchnic region. Hence, nitric oxide production occurs, to a measurable extent, in this area in healthy subjects, raising the question as to how various pathophysiological states might alter the relations between exogenous and endogenous sources of arginine as precursors of NO· and the relative contributions made by various organs to whole body (NO·) NO3 formation. These results also raise important questions about the use of nitric oxide synthase inhibitors in animal and human studies.

AB - Urinary nitrate (NO3) is the stable end product of nitric oxide, which is formed, in turn, from a guanidino nitrogen of arginine. We have conducted two experiments, each in four healthy adult men receiving a low nitrate diet for 7-10 days, to investigate the in vivo conversion of arginine to nitrate. In the first study [guanidino-15N2, 5,5-2H2]arginine was given on day 7 via a primed continuous intravenous infusion for 8 h. In the second study, the labeled arginine was given for 8 h by the intragastric route on day 7 and by the intravenous route on day 10. Measurement of 15NO3 output in urine collected for 24 h beginning at the time of the arginine tracer infusion revealed a more extensive transfer of 15N when the arginine tracer was given intragastricly. From the comparative labeling of 15NO3 after administration of the tracer arginine via the intragastric and intravenous routes, we estimate that 16% ± 2% of the daily production of nitrate arises from the metabolism of dietary arginine that is taken up during its "first pass" in the splanchnic region. Hence, nitric oxide production occurs, to a measurable extent, in this area in healthy subjects, raising the question as to how various pathophysiological states might alter the relations between exogenous and endogenous sources of arginine as precursors of NO· and the relative contributions made by various organs to whole body (NO·) NO3 formation. These results also raise important questions about the use of nitric oxide synthase inhibitors in animal and human studies.

UR - http://www.scopus.com/inward/record.url?scp=0027396811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027396811&partnerID=8YFLogxK

U2 - 10.1073/pnas.90.1.193

DO - 10.1073/pnas.90.1.193

M3 - Article

VL - 90

SP - 193

EP - 197

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 1

ER -